Cardiff Oncology, Inc. CRDF
1.24
(0.04)
(3.13%)
as of 25 Sep
- Market cap
- $99.6M
- P/E
- 0.0×
Follow CRDF
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
316.73 | 302.78 | 140.07 | 167.17 | 653.40 | 1,026.07 | 42.15 | 32.21 | 21.29 | 162.28 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(31.48) | (20.14) | (9.57) | (6.87) | (31.74) | (73.29) | (3.15) | (3.37) | (3.23) | (6.87) |
P/B ratio |
4.14 | 2.49 | 0.98 | 0.61 | 1.67 | 2.93 | 1.41 | 1.21 | 1.65 | 3.13 |
Price to Tangible BV |
4.14 | 2.49 | 0.98 | 0.61 | 1.67 | 2.93 | 1.41 | 1.21 | 1.65 | 3.13 |
EV/Sales |
222.28 | 171.82 | (8.55) | (98.51) | 269.83 | 670.57 | 7.59 | 38.61 | 32.78 | 106.24 |
EV/EBITDA |
0.00 | 0.00 | 0.09 | 0.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.48) | (3.11) | 0.14 | 1.12 | (4.20) | (15.04) | (0.14) | (1.11) | (0.71) | (1.30) |
EV/FCF |
(3.47) | (3.11) | 0.13 | 1.09 | (4.13) | (14.80) | (0.14) | (1.11) | (0.71) | (1.27) |
Quick Ratio |
3.57 | 6.89 | 7.19 | 13.58 | 21.55 | 21.46 | 2.17 | 3.98 | 2.10 | 4.87 |
Current Ratio |
3.67 | 7.08 | 7.41 | 14.25 | 22.28 | 21.79 | 2.37 | 4.37 | 2.40 | 5.00 |
Net Debt/EBITDA |
1.18 | 1.88 | 1.63 | 2.63 | 5.14 | 6.99 | 0.52 | 0.71 | 0.28 | 0.55 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.34% | 2.09% | 0.65% | 13.19% | 0.00% | 10.84% | 37.63% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.24 | 0.00 | 0.20 | 0.84 |
Asset Turnover |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 | 0.01 |
Operating CF/Net income |
0.83 | 0.83 | 0.74 | 0.87 | 0.81 | 0.72 | 0.79 | 0.69 | 0.93 | 0.79 |
Capex/Depreciation |
0.09 | 0.41 | 1.11 | (1.16) | (0.10) | (0.45) | (0.14) | 0.03 | (0.07) | (0.53) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (71.49%) | (59.54%) | (47.10%) | (31.39%) | (21.09%) | (33.36%) | (192.08%) | (232.13%) | (189.78%) | (114.59%) | |
| (57.68%) | (50.84%) | (41.92%) | (29.15%) | (19.92%) | (30.58%) | (122.58%) | (145.55%) | (88.67%) | (67.99%) | |
ROIC |
0.00% | 0.00% | 0.00% | (657.84%) | (664.25%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(103.53%) | (55.08%) | (60.79%) | (36.97%) | (20.23%) | (17.67%) | (224.26%) | (172.75%) | (313.63%) | (112.14%) |
Average Days of Receivables |
112.02 | 413.10 | 215.41 | 729.05 | 543.94 | 319.13 | 303.67 | 161.90 | 55.68 | 96.25 |
Research and Development Expense of Revenue |
5,957.67% | 5,395.61% | 6,732.99% | 7,022.54% | 4,840.11% | 3,069.67% | 4,563.45% | 2,158.08% | 1,559.70% | 3,937.71% |
Selling, General and Administrative Expense of Revenue |
2,398.65% | 1,827.53% | 2,672.75% | 3,414.77% | 3,297.49% | 2,245.08% | 2,355.23% | 2,116.20% | 2,816.17% | 6,034.93% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
960.03% | 696.93% | 923.98% | 1,102.59% | 900.84% | 482.24% | 361.77% | 574.83% | 793.95% | 1,969.12% |
Graham Net Nets |
0.23 | 0.39 | 0.96 | 1.57 | 0.58 | 0.34 | 0.54 | 0.71 | 0.34 | 0.24 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(24.56%) | (21.66%) | (60.78%) | (60.14%) | (11.81%) | (7.24%) | (244.35%) | (438.05%) | (245.21%) | (63.92%) |
Free Cash Flow Yield |
(20.21%) | (18.27%) | (46.04%) | (53.97%) | (10.00%) | (4.42%) | (129.12%) | (108.13%) | (217.33%) | (51.52%) |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.16 | 1.05 | 0.91 |
Operating CF per Share |
(0.57) | (0.79) | (0.69) | (0.78) | (0.59) | (0.78) | (2.22) | (5.66) | (48.30) | (74.08) |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.02) | (0.01) | (0.01) | (0.01) | 0.01 | (0.21) | (1.97) |
Free Cash Flow per Share |
(0.57) | (0.79) | (0.70) | (0.80) | (0.60) | (0.79) | (2.23) | (5.65) | (48.51) | (76.05) |
Cash per Share |
0.87 | 1.93 | 1.67 | 2.41 | 3.61 | 6.27 | 1.71 | 4.92 | 17.07 | 90.44 |
Shareholders Equity per Share |
0.68 | 1.74 | 1.56 | 2.44 | 3.60 | 6.14 | 1.22 | 4.33 | 13.50 | 47.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.68 | 1.74 | 1.56 | 2.44 | 3.60 | 6.14 | 1.22 | 4.33 | 13.50 | 47.18 |
Free Cash Flow |
(37.97) | (37.77) | (31.47) | (34.83) | (23.24) | (16.53) | (13.34) | (13.18) | (23.38) | (31.86) |
Working Capital |
43.73 | 81.63 | 66.97 | 103.48 | 139.57 | 127.24 | 6.57 | 9.84 | 5.52 | 31.15 |
Capital Expenditures |
(0.04) | (0.08) | (0.58) | (1.01) | (0.20) | (0.21) | (0.07) | 0.02 | (0.10) | (0.82) |
Net Current Asset Value |
43.63 | 80.81 | 65.51 | 101.44 | 137.00 | 126.79 | 5.58 | 8.68 | 3.69 | 14.77 |
EV/EBIT |
0.00 | 0.00 | 0.09 | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.07 | 0.12 | 1.19 | 2.61 | 0.57 | 0.58 | 0.28 | (0.06) | 0.20 | 2.16 |
Net Profit Margin |
(7,736.26%) | (6,655.20%) | (8,496.93%) | (10,033.16%) | (7,887.19%) | (6,174.32%) | (6,830.21%) | (5,089.88%) | (4,932.92%) | (10,293.36%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(0.84) | (0.22) | (0.42) | 0.68 | 5.39 | 0.75 | 0.56 | 0.66 | 0.56 | 0.41 |
Cash ROIC |
(37.13%) | (22.09%) | (22.22%) | (16.37%) | (8.24%) | (6.51%) | (73.55%) | (67.34%) | (160.04%) | (46.99%) |
Accounts Receivable Turnover |
1.24 | 1.29 | 0.92 | 0.59 | 0.84 | 1.40 | 1.32 | 3.09 | 5.69 | 3.83 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.12 | 0.36 | 0.00 | 0.00 | 0.80 | 1.85 | 1.59 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 3,569.70 | 1,050.47 | 0.00 | 0.00 | 406.11 | 166.28 | 238.45 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.48 | 0.53 | 0.53 | 0.65 | 0.43 | 0.26 | 0.19 | 0.12 | 0.09 | 0.10 |
Average Payables |
6.45 | 3.39 | 1.96 | 1.70 | 1.40 | 1.01 | 0.66 | 0.75 | 0.98 | 1.09 |
Average Assets |
79.54 | 89.41 | 98.91 | 132.87 | 142.14 | 73.91 | 13.63 | 13.23 | 28.12 | 57.70 |
Average Common Equity |
64.17 | 76.34 | 88.04 | 123.38 | 134.29 | 67.73 | 8.70 | 8.30 | 13.14 | 34.23 |
Columns are period end dates